In fact, different KIR profiles, are involved both immunoregulatory dysfunction and inflammatory processes underlying MS pathogenic mechanisms (Lorentzen et al., 2009; Fusco et al., 2010; García-León et al., 2011). This evidence concerns the gene KIR3DL1 and myeloid sarcoma.